A randomized, placebo-controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beings

Journal of Thoracic and Cardiovascular Surgery

Volumn 129, Issue 2, 2005, Pages 423-428

  Keshavjee, S ^a,e   Davis, R D ^b   Zamora, M R ^c   De Perrot, M ^a   Patterson, G A ^d  

^a UNIVERSITY OF TORONTO   (Canada)

^b DUKE UNIVERSITY   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d WASHINGTON UNIVERSITY   (United States)

^e TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT FACTOR I; PLACEBO;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EXTUBATION; FEMALE; GRAFT REJECTION; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION COMPLICATION; INTENSIVE CARE UNIT; ISCHEMIA; LUNG INSUFFICIENCY; LUNG PERFUSION; LUNG TRANSPLANTATION; MALE; MULTICENTER STUDY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECIPIENT; REPERFUSION INJURY; STATISTICAL SIGNIFICANCE; SURGICAL MORTALITY; TREATMENT OUTCOME; VENTILATOR;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CARDIOPULMONARY BYPASS; COMPLEMENT INACTIVATOR PROTEINS; COMPLEMENT SYSTEM PROTEINS; DOUBLE-BLIND METHOD; FEMALE; GRAFT REJECTION; HUMANS; LENGTH OF STAY; LUNG DISEASES; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; NORTH AMERICA; OXYGEN CONSUMPTION; POSTOPERATIVE COMPLICATIONS; RECEPTORS, COMPLEMENT; REPERFUSION INJURY; RESPIRATION, ARTIFICIAL; SURGICAL WOUND INFECTION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 12844265263     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2004.06.048     Document Type: Article

References (33)

1. E.P. Trulock, L.B. Edwards, D.O. Taylor, M.M. Boucek, P.J. Mohacsi, B.M. Keck The registry of the international society for heart and lung transplantation: twentieth official adult lung and heart-lung transplant report--2003 J Heart Lung Transplant. 22 2003 625 635
2. R.C. King, O.A. Binns, F. Rodriguez, R.C. Kanithanon, T.M. Daniel, W.D. Spotnitz Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation Ann Thorac Surg. 69 2000 1681 1685
3. J.D. Christie, J.E. Bavaria, H.I. Palevsky, L. Litzky, N.P. Blumenthal, L.R. Kaiser Primary graft failure following lung transplantation Chest. 114 1998 51 60
4. S. Fischer, A. Matte-Martyn, M. de Perrot, T.K. Waddell, Y. Sekine, M. Hutcheon Low-potassium dextran preservation solution improves lung function after human lung transplantation J Thorac Cardiovasc Surg. 121 2001 594 596
5. T.K. Waddell, R.M. Gorczynski, K.N. DeCampos, G.A. Patterson, A.S. Slutsky Major histocompatibility complex expression and lung ischemia- reperfusion in rats Ann Thorac Surg. 62 1996 866 872
6. S.M. Fiser, C.G. Tribble, S.M. Long, A.K. Kaza, J.A. Kern, D.R. Jones, M.K. Robbins, I.L. Kron Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome Ann Thorac Surg. 73 2002 1041 1047
7. K.E. Sommers, B.P. Griffith, R.L. Hardesty, R.J. Keenan Early lung allograft function in twin recipients from the same donor: risk factor analysis Ann Thorac Surg. 62 1996 784 790
8. M. de Perrot, M. Liu, T.K. Waddell, S. Keshavjee Ischemia-reperfusion induced lung injury State-of-the-art Am J Respir Crit Care Med. 167 2003 490 511
9. K.M. McRae Pulmonary transplantation Curr Opin Anaesthesiol. 13 2000 53 59
10. M.M. Frank Complement in the pathophysiology of human disease N Engl J Med. 316 1987 1525 1530
11. Y. Naka, H.C. Marsh, S.M. Scesney, M.C. Oz, D.J. Pinsky Complement activation as a cause for primary graft failure in an isogeneic rat model of hypothermic lung preservation and transplantation Transplantation. 64 1997 1248 1255
12. M.J. Bishop, P.C. Giclas, S.M. Guidotti, M.L. Su, E.Y. Chi Complement activation is a secondary rather than a causative factor in rabbit pulmonary artery ischemia/reperfusion injury Am Rev Respir Dis. 143 1991 386 390
13. A.F. Pierre, A.M. Xavier, M. Liu, S.D. Cassivi, T.F. Lindsay, H.C. Marsh Effect of complement inhibition with soluble complement receptor 1 on pig allotransplant lung function Transplantation. 66 1998 723 732
14. R.A. Schmid, A. Zollinger, T. Singer, S. Hillinger, J.R. Leon-Wyss, O.M. Schob Effect of soluble complement receptor type 1 on reperfusion edema and neutrophil migration after lung allotransplantation in swine J Thorac Cardiovasc Surg. 116 1998 90 97
15. J.L. Zimmerman, R.P. Dellinger, R.C. Straube, J.L. Levin Phase I trial of the recombinant soluble complement receptor 1 in acute lung injury and acute respiratory distress syndrome Crit Care Med. 28 2000 3149 3154
16. M. de Perrot, K. Young, Y. Imai, M. Liu, T.K. Waddell, S. Fischer Recipient T cells mediate reperfusion injury after lung transplantation in the rat J Immunol. 171 2003 4995 5002
17. J. Kohl Anaphylatoxins and infectious and non-infectious inflammatory diseases Mol Immunol. 38 2001 175 187
18. W. Zhou, C.A. Farrar, K. Abe, J.R. Pratt, J.E. Marsh, Y. Wang Predominant role for C5b-9 in renal ischemia/reperfusion injury J Clin Invest. 105 2000 1363 1371
19. C.L. Ivey, F.M. Williams, P.D. Collins, P.J. Jose, T.J. Williams Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit Evidence for a role for C5a and interleukin-8 J Clin Invest. 95 1995 2720 2728
20. E.J. Tanhehco, H. Lee, B.R. Lucchesi Sublytic complement attack reduces infarct size in rabbit isolated hearts: evidence for C5a-mediated cardioprotection Immunopharmacology. 49 2000 391 399
21. R.D. Riley, H. Sato, Z.Q. Zhao, V.H. Thourani, J.E. Jordan, A.X. Fernandez Recombinant human complement C5a receptor antagonist reduces infarct size after surgical revascularization J Thorac Cardiovasc Surg. 120 2000 350 358
22. E.A. Amsterdam, G.L. Stahl, H.L. Pan, S.V. Rendig, M.P. Fletcher, J.C. Longhurst Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs Am J Physiol. 268 1 Pt 2 1995 H448 57
23. N.P. Stimler, T.E. Hugli, C.M. Bloor Pulmonary injury induced by C3a and C5a anaphylatoxins Am J Pathol. 100 1980 327 338
24. M.S. Mulligan, E. Schmid, B. Beck-Schimmer, G.O. Till, H.P. Friedl, R.B. Brauer Requirement and role of C5a in acute lung inflammatory injury in rats J Clin Invest. 98 1996 503 512
25. T. Heller, M. Hennecke, U. Baumann, J.E. Gessner, A.M. zu Vilsendorf, M. Baensch Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia/reperfusion injury J Immunol. 163 1999 985 994
26. P. Rioux TP-10 (AVANT Immunotherapeutics) Curr Opin Investig Drugs. 2 2001 364 371
27. S.M. Shandelya, P. Kuppusamy, A. Herskowitz, M.L. Weisfeldt, J.L. Zweier Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart Evidence that complement activation is required for neutrophil-mediated reperfusion injury Circulation. 88 1993 2812 2826
28. T.G. Lehmann, T.A. Koeppel, M. Kirschfink, M.M. Gebhard, C. Herfarth, G.et al Otto Complement inhibition by soluble complement receptor type 1 improves microcirculation after rat liver transplantation Transplantation. 66 1998 717 722
29. A.T. Eror, A. Stojadinovic, B.W. Starnes, S.C. Makrides, G.C. Tsokos, T. Shea-Donohue Antiinflammatory effects of soluble complement receptor type 1 promote rapid recovery of ischemia/reperfusion injury in rat small intestine Clin Immunol. 90 1999 266 275
30. T. Wittwer, M. Grote, P. Oppelt, U. Franke, H.J. Schaefers, T. Wahlers Impact of PAF antagonist BN 52021 (Ginkolide B) on post-ischemic graft function in clinical lung transplantation J Heart Lung Transplant. 20 2001 358 363
31. M. Meade, J.T. Granton, A. Matte-Martyn, K. McRae, B. Weaver, P.M. Cripps A randomized trial of inhaled nitric oxide to prevent ischemia-reperfusion injury after lung transplantation Am J Respir Crit Care Med. 167 2003 1483 1489
32. R.A. Schmid, S. Hillinger, J. Hamacher, U. Stammberger TP20 is superior to TP10 in reducing ischemia/reperfusion injury in rat lung grafts Transplant Proc. 33 2001 948 949
33. U. Stammberger, J. Hamacher, S. Hillinger, R.A. Schmid sCR1sLe ameliorates ischemia/reperfusion injury in experimental lung transplantation J Thorac Cardiovasc Surg. 120 2000 1078 1084